News

The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has reached its enrollment goal of 108,508 women, as announced today by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). The study, funded by the National… Learn more
POSTED: 1/15/2025
Latest News, Upcoming Events, Notice of Funding Opportunities (NOFOs): Cancer Risk and Prevention
POSTED: 1/14/2025
An illustration of a test tube filled with blood next to a clipboard.
The National Cancer Institute (NCI) has selected two assays to be included in the Vanguard Study: Avantect® Multi-Cancer Detection Test by ClearNote Health and Shield™ Multi-Cancer Detection Test by Guardant Health.
POSTED: 1/7/2025